FAM242F

Across TCGA pan-cancer cohorts, FAM242F RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated FAM242F data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher FAM242F RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM242F expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

THCA, CHOL, and UVM are the cancer types where FAM242F RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	II,III,IV	0.796	0.962	<.001	117	view →
CHOL	DFS	Tertile	All	0.028	0.524	<.001	54	view →
UVM	DFS	Tertile	III,IV	0.164	0.701	.003	45	view →
BLCA	OS	Tertile	IV	0.157	0.602	.003	18	view →
ACC	OS	Tertile	All	0.147	0.685	.018	18	view →
ESCA	DFS	Tertile	All	0.381	0.862	.006	13	view →
SKCM	DFS	Tertile	III,IV	0.336	0.587	.012	12	view →
MESO	OS	Quartile	II,III,IV	0.222	0.620	.011	12	view →
PAAD	OS	Median	II,III,IV	0.349	0.513	.008	9	view →
KIRC	DFS	Quartile	III,IV	0.526	0.671	.041	6	view →
LAML	DFS	Median	All	0.676	0.433	.007	6	view →
CESC	OS	Tertile	II,III,IV	0.319	0.691	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

FAM242F–THCA (OS)

Open the THCA breakdown →